News

Subscribe to our feed.

Endocyte appoints Dr. Alison A. Armour as Chief Medical Officer

August 4, 2015 — WEST LAFAYETTE, Ind. - Endocyte Inc., a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that Alison A. Armour, M.B., Ch.B., B.Sc., M.Sc., M.D., MRCP., FRCR, has been appointed as chief medical officer. Read More

Endocyte to present at the 2015 Wedbush PacGrow Healthcare Conference

August 3, 2015 — WEST LAFAYETTE, Ind. - Endocyte Inc., a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that the company's management team will present at the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, Aug. 11, at 3:05 p.m. EDT. The conference will be held at the Le Parker Meridien Hotel inNew York. Read More